The gamma emitting impurities in Tc solution obtained from enriched molybdenum Mo metallic target after its irradiation in a cyclotron were measured using a high-purity germanium (HPGe) detector. The radioactivity range of tested samples of Tc was rather low, in the range from 0.34 to 2.39 MBq, thus creating a challenge to investigate the standard measurement HPGe system for impurity detection and quantification. In the process of Tc separation from irradiated target the AnaLig® Tc-02 resin, Dionex H and Alumina A columns were used. Fractions of eluates from various steps of separation process were taken and measured for radionuclidic purity. The overall measurement sensitivity of gamma emitters in terms of minimum detectable activity (MDA) was found at the level of 14-70Bq with emission lines in range of 36 - 1836keV resulting in impurity content range of 6.7 × 10 to 3.4 × 10 % for Tc, Tc, Tc, Tc, Tc, Tc, Tc Nb, Nb, Mo contaminants and 9.4 × 10 % for Tc. The usefulness of the chosen measurement conditions and the method applied to testing the potential contaminators was proved by reaching satisfactory results of MDAs less than the criteria of impurity concentration of all nuclides specified in the European Pharmacopoeia.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.apradiso.2017.10.021DOI Listing

Publication Analysis

Top Keywords

impurities tc-99m
4
tc-99m radiopharmaceutical
4
radiopharmaceutical solution
4
solution mo-100
4
mo-100 cyclotron
4
cyclotron gamma
4
gamma emitting
4
emitting impurities
4
impurities solution
4
solution enriched
4

Similar Publications

Electrochemical separation technology has brought a renaissance in the field of nuclear medicine towards obtaining clinical-grade radiometals for preparation of a wide variety of radiopharmaceuticals. This article is a comprehensive summary of the electrochemical processes developed for the separation of radiometals that could be used for diagnostic or therapeutic applications in nuclear medicine. For using electrochemistry as a tool for the separation of radiometals, intricate knowledge is essential to understand the basic parameters of electrochemical separation processes which include applied potential, selection of electrolyte, choice of the electrode, the temperature of the electrolyte, pH of the electrolyte and time of electrolysis.

View Article and Find Full Text PDF

Background: Technetium-99 m-labelled macroaggregated human serum albumin ([99mTc]Tc-MAA) is commonly used for lung perfusion scintigraphy. The European Pharmacopoeia (Eu.Ph.

View Article and Find Full Text PDF

Thin-layer chromatography (TLC) is commonly employed to screen technetium-99m labeled polymer nanoparticle batches for unreduced pertechnetate and radio-colloidal impurities. Although this method is widely accepted, our findings applying radiolabeled PLGA/PLA-PEG nanoparticles underscore its lack of transferability between different settings and its limitations as a standalone quality control tool. While TLC profiles may appear similar for purified and radiocolloid containing nanoparticle formulations, their in vivo behavior can vary significantly, as demonstrated by discrepancies between TLC results and single-photon emission computed tomography (SPECT) and biodistribution data.

View Article and Find Full Text PDF

Background: Parkinson's disease (PD) is characterized by the degeneration of dopaminergic neurons in the substantia nigra. SPECT imaging using technetium-99m [Tc] labeled trodat is the choice of imaging to differentiate PD from its other forms like drug-induced PD.

Aims And Objectives: The main objective of our study was to prepare in-house sterile formulation of [Tc]Tc-trodat and use in clinics.

View Article and Find Full Text PDF

Validation of HPLC and TLC analytical methods to determine radiochemical purity of Tc-cAbVCAM1-5, a new experimental radiotracer.

J Pharm Biomed Anal

August 2024

Univ. Grenoble Alpes, Pharmacy Department, CHU Grenoble Alpes, Grenoble 38000,  France; Univ. Grenoble Alpes, Nuclear Medicine Department, CHU Grenoble Alpes, Grenoble 38000,  France; Univ. Grenoble Alpes, INSERM, LRB, UMR 1039, Grenoble 38000, France. Electronic address:

Cardiovascular diseases, including fatal myocardial infarctions from atheromatous plaques, are the primary global mortality cause. Detecting stenotic atheromatous plaques is possible through coronary angiography, but vulnerable plaques with eccentric remodeling are undetectable with current diagnostic methods. Addressing this challenge, our group developed a radiopharmaceutical drug targeting vascular cell adhesion molecule 1 (VCAM-1), radiolabeled with technetium-99m.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!